Charles River Laboratories Cash on Hand 2010-2024 | CRL

Charles River Laboratories cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Charles River Laboratories cash on hand for the quarter ending March 31, 2024 was $0.327B, a 62.23% increase year-over-year.
  • Charles River Laboratories cash on hand for 2023 was $0.277B, a 18.32% increase from 2022.
  • Charles River Laboratories cash on hand for 2022 was $0.234B, a 3.03% decline from 2021.
  • Charles River Laboratories cash on hand for 2021 was $0.241B, a 5.6% increase from 2020.
Charles River Laboratories Annual Cash on Hand
(Millions of US $)
2023 $277
2022 $234
2021 $241
2020 $228
2019 $238
2018 $195
2017 $164
2016 $118
2015 $118
2014 $160
2013 $156
2012 $110
2011 $69
2010 $179
2009 $183
Charles River Laboratories Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $327
2023-12-31 $277
2023-09-30 $157
2023-06-30 $200
2023-03-31 $202
2022-12-31 $234
2022-09-30 $194
2022-06-30 $200
2022-03-31 $242
2021-12-31 $241
2021-09-30 $213
2021-06-30 $223
2021-03-31 $465
2020-12-31 $228
2020-09-30 $243
2020-06-30 $402
2020-03-31 $372
2019-12-31 $238
2019-09-30 $165
2019-06-30 $201
2019-03-31 $126
2018-12-31 $195
2018-09-30 $139
2018-06-30 $192
2018-03-31 $188
2017-12-31 $164
2017-09-30 $124
2017-06-30 $116
2017-03-31 $132
2016-12-31 $118
2016-09-30 $106
2016-06-30 $155
2016-03-31 $157
2015-12-31 $118
2015-09-30 $74
2015-06-30 $151
2015-03-31 $152
2014-12-31 $160
2014-09-30 $131
2014-06-30 $117
2014-03-31 $170
2013-12-31 $156
2013-09-30 $130
2013-06-30 $114
2013-03-31 $100
2012-12-31 $110
2012-09-30 $83
2012-06-30 $76
2012-03-31 $61
2011-12-31 $69
2011-09-30 $81
2011-06-30 $146
2011-03-31 $159
2010-12-31 $179
2010-09-30 $137
2010-06-30 $219
2010-03-31 $222
2009-12-31 $183
2009-09-30 $192
2009-06-30 $155
2009-03-31 $170
Sector Industry Market Cap Revenue
Medical Medical Services $10.798B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.295B 15.60
Cencora (COR) United States $47.007B 18.33
ICON (ICLR) Ireland $26.068B 24.61
DiDi Global (DIDIY) China $21.483B 0.00
Avantor (AVTR) United States $14.638B 21.55
CochLear (CHEOY) Australia $14.016B 0.00
Revvity (RVTY) United States $13.265B 23.27
Natera (NTRA) United States $13.164B 0.00
Medpace Holdings (MEDP) United States $12.413B 40.84
Viatris (VTRS) United States $12.216B 3.65
EUROFINS SCIENT (ERFSF) Luxembourg $10.939B 0.00
Solventum (SOLV) United States $9.292B 0.00
Sonic Healthcare (SKHHY) Australia $8.560B 0.00
HealthEquity (HQY) United States $7.157B 45.96
Bausch + Lomb (BLCO) Canada $5.309B 21.25
Organon (OGN) United States $5.259B 4.99
Doximity (DOCS) United States $5.034B 35.26
PACS (PACS) United States $4.404B 0.00
Life Times (LTH) United States $3.653B 38.27
Sotera Health (SHC) United States $3.278B 16.08
Surgery Partners (SGRY) United States $3.011B 27.55
GoodRx Holdings (GDRX) United States $2.927B 111.43
Agilon Health (AGL) United States $2.612B 0.00
Progyny (PGNY) United States $2.413B 41.54
NovoCure (NVCR) Jersey $2.063B 0.00
AMN Healthcare Services Inc (AMN) United States $2.019B 8.00
Premier (PINC) United States $1.914B 8.19
BrightSpring Health Services (BTSG) United States $1.785B 0.00
Teladoc Health (TDOC) United States $1.637B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.356B 0.00
Establishment Labs Holdings (ESTA) $1.176B 0.00
CareDx (CDNA) United States $0.728B 0.00
Embecta (EMBC) United States $0.719B 4.89
GeneDx Holdings (WGS) United States $0.703B 0.00
Pediatrix Medical (MD) United States $0.649B 6.88
InnovAge Holding (INNV) United States $0.619B 0.00
Auna S.A (AUNA) Luxembourg $0.594B 0.00
Enhabit (EHAB) United States $0.442B 44.05
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
COMPASS Pathways (CMPS) United Kingdom $0.432B 0.00
ModivCare (MODV) United States $0.370B 6.93
Sonida Senior Living (SNDA) United States $0.370B 0.00
DocGo (DCGO) United States $0.313B 17.11
LifeMD (LFMD) United States $0.300B 0.00
Sharecare (SHCR) United States $0.281B 0.00
MultiPlan (MPLN) United States $0.247B 0.00
Sera Prognostics (SERA) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.219B 0.00
Ascend Wellness Holdings (AAWH) United States $0.189B 0.00
Biodesix (BDSX) United States $0.185B 0.00
So-Young (SY) China $0.111B 53.55
Pono Capital Two (PTWO) United States $0.071B 0.00
Co-Diagnostics (CODX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.043B 5.83
IceCure Medical (ICCM) Israel $0.034B 0.00
Oncology Institute (TOI) United States $0.031B 0.00
Nutex Health (NUTX) United States $0.028B 0.00
Singular Genomics Systems (OMIC) United States $0.024B 0.00
OncoCyte (OCX) United States $0.024B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
KindlyMD (KDLY) $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.016B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.001B 0.00